Jeffrey A. Rona

CIK: 0001311404

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

OVID

Ovid Therapeutics Inc.

Officer

SANW

S&W Seed Co

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

OVID
Ovid Therapeutics Inc.
Feb 26, 2026
Award(A)
Direct
68.1K shares-
OVID
Ovid Therapeutics Inc.
Feb 23, 2026
Sale(S)
Direct
8.5K shares at avg. $1.45$12K
OVID
Ovid Therapeutics Inc.
Feb 26, 2025
Sale(S)
Direct
3.9K shares at avg. $0.56$2K
OVID
Ovid Therapeutics Inc.
Feb 20, 2025
Award(A)
Direct
43.8K shares-
SANW
S&W Seed Co
Dec 17, 2024
Award(A)
Direct
12.7K shares-

		Type	Shares	Price		Ownership
Feb 26, 2026	OVID Ovid Therapeutics Inc.	Award(A)	68,125	-	$0	Direct
Feb 23, 2026	OVID Ovid Therapeutics Inc.	Sale(S)	8,541	$1.45	$12,384	Direct
Feb 26, 2025	OVID Ovid Therapeutics Inc.	Sale(S)	3,902	$0.56	$2,185	Direct
Feb 20, 2025	OVID Ovid Therapeutics Inc.	Award(A)	43,750	-	-	Direct
Dec 17, 2024	SANW S&W Seed Co	Award(A)	12,725	-	$0	Direct

1-5 of 5 transactions

About Rona Jeffrey A

Rona Jeffrey A (SEC CIK 0001311404) files insider reports with the SEC as CBFO of Ovid Therapeutics Inc. (OVID) and Director of S&W Seed Co (SANW).

Signal8 holds 4 ownership filings by Rona Jeffrey A, all Form 4s, filed between Dec 19, 2024 and Mar 2, 2026. Those filings report 5 transactions, from Dec 17, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rona Jeffrey A's filings is in NEW YORK, NY.

Recent filings by Rona Jeffrey A

Feb 26, 2026: Grant or award of OVID shares (Form 4, code A).
Feb 23, 2026: Open-market sale of OVID shares (Form 4, code S).
Feb 26, 2025: Open-market sale of OVID shares (Form 4, code S).
Feb 20, 2025: Grant or award of OVID shares (Form 4, code A).
Dec 17, 2024: Grant or award of SANW shares (Form 4, code A).

Other insiders filing for Ovid Therapeutics Inc. (OVID)

Carter Charles Ross, Chief Financial Officer
Greka Anna, Director
PAPADOPOULOS STELIOS, Director
Friedman Bart, Director
Fitzgerald Kevin Joseph, Director
LEVIN JEREMY M, Director

How to read Form 4 transaction codes